NIO Inc. vs Tilray Brands Inc — how do they compare? NIO Inc. trades at $3.69 (market cap $9.50B), while Tilray Brands Inc trades at $4.21 (market cap $577.15M). The key difference: NIO Inc. is far larger — about 16.5× Tilray Brands Inc's market cap. Which is the better fit depends on your goals.
| NIO | TLRY | |
|---|---|---|
Market Cap | $9.50B | $577.15M |
Sector | Consumer Cyclical | Health |
52-Week High | $7.89 | $21.00 |
52-Week Low | $3.70 | $3.88 |
Enterprise Value | $7.40B | $744.29M |
Signals from Pluang's Aura AI — not financial advice
NIO trades at $3.79, down 0.26% today, with a bearish technical signal despite recent earnings beats. The company reported Q2 2026 revenue growth of 69.1% year-over-year to $4.74 billion (Seeking Alpha, 2026-09-03), but missed revenue expectations. Vehicle margins improved to 18.4%, and cash flow turned positive, yet net losses persist. Analyst consensus is mixed, with a $5.50 price target suggesting 45% upside from current levels.
Outlook: NIO shows operational progress with narrowing losses and brand diversification, but high debt and Chinese EV competition pose risks. The stock's low P/S ratio of 0.54 indicates potential undervaluation if profitability improves. Investors face volatility from macroeconomic headwinds and execution challenges in achieving sustained positive earnings.
TLRY trades at $4.30, down 4.44% with a bearish technical outlook. The company reported record fiscal 2026 revenue of $915M but continues to post significant losses with a -13.27% net margin. Recent news highlights expansion in spirits distribution and medical cannabis production, though regulatory uncertainty weighs on sentiment. The stock trades below book value with a P/S of 0.51 and P/B of 0.36, suggesting potential undervaluation despite profitability challenges.
TLRY presents a high-risk opportunity with mixed signals. The discounted valuation and expanding beverage/alcohol business offer upside potential, but persistent losses, negative cash flow, and cannabis regulatory delays create substantial headwinds. Analyst consensus leans cautious with 65% hold ratings, reflecting the stock's speculative nature amid ongoing operational challenges.
Trailing returns across standard periods
Latest headlines on both assets
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →